Yoon-Jong Ryu

Dr. Yoon-Jong Ryu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2025 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
JJJeon Yeob Jang
Jeon Yeob Jang
GKGeun-Jeon Kim
Geun-Jeon Kim
SKSang-Yeon Kim
Sang-Yeon Kim
DLDong Kun Lee
Dong Kun Lee
MKMinsu Kwon
Minsu Kwon
KCKwang-Jae Cho
Kwang-Jae Cho
Objectives. Effective treatment of laryngeal cancer requires clinical decision-making that balances survival outcomes with the preservation of essential functions, such as voice and swallowing. This study, led by the Clinical Practice Guideline Committee of the Korean Society of Head and Neck Surgery, aims to establish evidence-based recommendations to guide surgeons in optimizing treatment decisions for patients with laryngeal cancer.Methods. A literature search was performed in the PubMed, Embase, Cochrane Library, and KoreaMed databases by a literature search expert and subsequently reviewed by a panel of 39 committee experts. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) method was employed to assess the quality of evidence and develop and report the recommendations. The strength of each recommendation reflects the guideline panel’s confidence that the benefits of an intervention outweigh its risks for the target population. After drafting the guidelines, Delphi questionnaires were distributed to members of the Korean Society of Head and Neck Surgery and an external reviewer panel.Results. In total, 15 evidence-based recommendations are provided, addressing six critical aspects of laryngeal cancer treatment: early-stage treatment, treatment of locally advanced cancer, neck management, adjuvant therapy, swallowing rehabilitation, and salvage treatment for recurrent tumors.Conclusion. The guidelines provide evidence-based, validated recommendations to support clinicians in making optimal treatment decisions for laryngeal cancer.

31 January 2018 in Audiology and Speech Research
Verified
Journal Article
Open access
PDF file
ENEui-Cheol Nam
Eui-Cheol Nam
YRYoon-Jong Ryu
Yoon-Jong Ryu
젊은 고도비만 여성에서 발생한 특발성 두개내고혈압 기원의 박동성 이명 1예 남 의 철 1,2 •유 윤 종 2 강원대학교 의학전문대학원 이비인후과학교실 1 , 강원대학교병원 이비인후과

1 January 2014 in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
Verified
Journal Article
Closed access
PDF file
JLJae Hyun Lim
Jae Hyun Lim
SLSang Yeon Lee
Sang Yeon Lee
YRYoon-Jong Ryu
Yoon-Jong Ryu
JHJ. Hun Hah
J. Hun Hah
Lim JH, et al. Korean J Otorhinolaryngol-Head Neck Surg. 2014 Oct;57(10):723-726. http://dx.doi.org/10.3342/kjorl-hns.2014.57.10.723

1 January 2016 in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
Verified
Journal Article
Open access
PDF file
BKBo Hae Kim
Bo Hae Kim
YRYoon-Jong Ryu
Yoon-Jong Ryu
YJYoung Ho Jung
Young Ho Jung
Kim BH, et al. Korean J Otorhinolaryngol-Head Neck Surg. 2016 May;59(5):339-345. http://dx.doi.org/10.3342/kjorl-hns.2016.59.5.339

29 June 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
YJYoung Ju Jin
Young Ju Jin
JYJeong-Ah Yoon
Jeong-Ah Yoon
YRYoon-Jong Ryu
Yoon-Jong Ryu
Background: Burning mouth syndrome (BMS) is a chronic orofacial pain disorder characterized by persistent intraoral burning recurring daily for at least 2 h over more than 3 months, without explanatory mucosal or laboratory findings. It affects 1.7–7.7% of the population, predominantly perimenopausal and postmenopausal women, and conventional pharmacotherapy offers only partial relief. Aim: This narrative review examines the associative and mechanistic evidence linking the oral microbiome to BMS and evaluates the rationale for lactic acid bacteria (LAB) as a candidate therapeutic strategy. Methods: PubMed/MEDLINE, Scopus, and Web of Science were searched for English-language literature on BMS, the oral microbiome, and probiotics, supplemented by mechanistic data from related conditions. Results: BMS patients may exhibit a compositionally distinct salivary microbiome, with reduced alpha diversity in psychiatric-comorbid subsets, though findings are heterogeneous. LAB, particularly Lacticaseibacillus paracasei, show antimicrobial and immunomodulatory properties relevant to oral homeostasis, but direct clinical evidence in BMS remains scarce and largely preclinical. Conclusions: Current evidence is predominantly cross-sectional and associative; the oral dysbiosis–BMS link and the therapeutic potential of LAB should be regarded as hypothesis-generating, warranting biomarker-anchored, strain-specific randomized trials.

4 June 2026 in Auris Nasus Larynx
Verified
Journal Article
Closed access
YJYoung Ju Jin
Young Ju Jin
WNWoo-Hyun Nam
Woo-Hyun Nam
HCHyo Geun Choi
Hyo Geun Choi
Mi Jung Jung KwonMi Jung Jung Kwon
Mi Jung Jung Kwon
JKJi Hee Kim
Ji Hee Kim
YRYoon-Jong Ryu
Yoon-Jong Ryu